Pharmacokinetics and bioavailability of green tea catechins

Phytochemicals: Mechanisms of Action

Volumn , Issue , 2003, Pages 35-49

  Cai, Yan ^a   Chow, H H Sherry ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898057689     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (60)

1. Katiyar, S.K. and Mukhtar, H., Tea consumption and cancer, World Rev. Nutr. Diet., 79, 154, 1996.
2. Liao, S., Kao, Y.H., and Hiipakka, R.A., Green tea: biochemical and biological basis for health benefits, Vita. Horm., 62, 1, 2001.
3. Riemersma, R.A. et al., Tea flavonoids and cardiovascular health, QJM, 94, 277, 2001.
4. Wargovich, M.J. et al., Herbals, cancer prevention and health, J. Nutr., 131, 3034S, 2001.
5. McKay, D.L. and Blumberg, J.B., The role of tea in human health: an update, J. Amer. Coll. Nutr., 21, 1, 2002.
6. Serafini, M., Ghiselli, A., and Ferro-Luzzi, A., In vivo antioxidant effect of green and black tea in man, Eur. J. Clin. Nutr., 50, 28, 1996.
7. Dreosti, I.E., Wargovich, M.J., and Yang, C.S., Inhibition of carcinogenesis by tea: the evidence from experimental studies, Crit. Rev. Food Sci. Nutr., 37, 761, 1997.
8. Nakagawa, K. et al., Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans, J. Agric. Food Chem., 47, 3967, 1999.
9. Klaunig, J.E. et al., The effect of tea consumption on oxidative stress in smokers and nonsmokers, Proc. Soc. Exp. Biol. Med., 220, 249, 1999.
10. Leung, L.K. et al., Theaflavins in black tea and catechins in green tea are equally effective antioxidants, J. Nutr., 131, 2248, 2001.
11. Wang, Z.Y., Zhou, Z.C., and Bickers, D.R., Inhibition of chemical and photocarcinogenesis in murine skin by green tea polyphenols, Proc. Am. Assoc. Cancer Res., 31, 159, 1990.
12. Huang, M.T. et al., Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin, Carcinogenesis, 13, 947, 1992.
13. Fesus, L., Szondy, Z., and Uray, I., Probing the molecular program of apoptosis by cancer chemopreventive agents, J. Cell. Biochem., 22S, 151, 1995.
14. Bu-Abbas, A. et al., Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea, Carcinogenesis, 15, 2575, 1994.
15. Obermeier, M.T., White, R.E., and Yang, C.S., Effects of bioflavonoids on hepatic P450 activities, Xenobiotica, 25, 575, 1995.
16. Katiyar, S.K. et al., Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethyl benz(a)anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea, Cancer Res., 52, 6890, 1992a.
17. Katiyar, S.K. et al., Protection against N-nitrosodiethylamine and benzo (a) pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea, Carcinogenesis, 14, 849, 1993.
18. Kono, S. et al. A case-control study of gastric cancer and diet in northern Kyushu, Japan, Jpn. J. Cancer Res., 79, 1067, 1988.
19. Oguni, I., Chen, S.J., and Lin, P.J., Protection against cancer risk by Japanese green tea, Prev. Med., 21, 332, 1992.
20. Hansson, L.E. et al., Diet and risk of gastric cancer. A population-based case-control study in Sweden, Int. J. Cancer, 55, 181, 1993.
21. Gao, Y.T. et al., Reduced risk of esophageal cancer associated with green tea consumption, J. Natl. Cancer Inst., 86, 855, 1994.
22. Yu, G.P et al., Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China, Cancer Causes Control, 6, 532, 1995.
23. Zheng, W. et al., Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women, Am, J. Epidemiol., 144, 175, 1996.
24. Stocks, P., Cancer mortality in relation to national consumption of cigarettes, solid fuel, tea and coffee, Br. J. Cancer, 24, 215, 1970.
25. Heilbrun, L.K., Nomura, A., and Stemmermann, G.N., Black tea consumption and cancer risk: a prospective study, Br. J. Cancer, 54, 677, 1986.
26. Kinlen, L.J. et al., Tea consumption and cancer, Br. J. Cancer, 58, 397, 1988.
27. La Vecchia, C. et al., Tea consumption and cancer risk, Nutr. Cancer, 17, 27, 1992.
28. Lu, C.M. et al., Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan, Urology, 54, 823, 1999.
29. Zhu, M., Chen, Y. and Li, R.C., Oral absorption and bioavailability of tea catechins, Planta Medica, 66, 444, 2000.
30. Lin, P.W., Hemodynamic changes after hepatectomy in rats studied with radioactive microspheres, J. Formos. Med. Assoc., 89, 177, 1990.
31. Hashimoto, T. et al., Interaction of tea catechins with lipid bilayers investigated with liposome systems, Biosci. Biotechnol. Biochem., 63, 2252, 1999.
32. Fabre, J., Blanchard, P and Rudhardt, M., Pharmacokinetics of ampicillin, cephal-othin and doxycycline in various tissues of the rat, Chemotherapy, 23, 129, 1977.
33. Maza, A. et al., Influence of partial hepatectomy on theophylline pharmacokinetics in rats, J. Pharm. Sci., 85, 1133, 1996.
34. Burstein, A.H. et al., Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats, Epilepsy Res., 34, 129, 1999.
35. Zhu, M., Chen, Y., and Li, R.C., Pharmacokinetics and system linearity of tea catechins in rat, Xenobiotica, 31, 51, 2001.
36. Lee, M.J. et al., Analysis of plasma and urinary tea polyphenols in human subjects, Cancer Epidemiol. Biomark. Prev., 4, 393, 1995.
37. Yang, C.S. et al., Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers, Cancer Epidemiol. Biomark. Prev., 7, 351, 1998.
38. Chow, H.H. et al., Phase I pharmacokinetic study of tea polyphenols following singledose administration of epigallocatechin gallate and polyphenon E, Cancer Epidemiol. Biomark. Prev., 10, 53, 2001.
39. Lee, M.J. et al., Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability, Cancer Epidemiol. Biomark. Prev., 11, 1025, 2002.
40. Chen, L. et al. Absorption, distribution, elimination of tea polyphenols in rats, Drug Metab. Dispos., 25, 1045, 1997.
41. Cai, Y., Anavy, N.D., and Chow, H.H., Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats, Drug Metab. Dispos., 30, 1246, 2002.
42. Kao, Y.H., Hiipakka, R.A., and Liao, S., Modulation of endocrine systems and food intake by green tea epigallocatechin gallate, Endocrinology, 141, 980, 2000.
43. Kuhnle, G. et al., Epicatechin and catechin are O-methylated and glucuronidated in the small intestine, Biochem. Biophys. Res. Commun., 277, 507, 2000.
44. Vaidyanathan, J.B. and Walle, T., Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2, Pharm. Res., 18, 1420, 2001.
45. Kim, S. et al., Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols, Nutr. Cancer, 37, 41, 2000.
46. Nakagawa, K. and Miyazawa, T., Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat, J. Nutr. Sci. Vitaminol., 43, 679, 1997.
47. Suganuma, M. et al., Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue, Carcinogenesis, 19, 1771, 1998.
48. Li, C. et al., Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion, Chem. Res. Toxicol., 13, 177, 2000.
49. Kida, K. et al., Identification of biliary metabolites of (-)-epigallocatechin gallate in rats, J. Agric. Food Chem., 48, 4151, 2000.
50. 3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration, J. Agric. Food Chem., 49, 1042, 2001.
51. Piskula, M.K. and Terao, J., Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues, J. Nutr., 128, 1172, 1998.
52. Okushio, K. et al., Methylation of tea catechins by rat liver homogenates, Biosci. Biotechnol. Biochem., 63, 430, 1999.
53. Okushio, K. et al., Identification of (-)-epicatechin metabolites and their metabolic fate in the rat, Drug Metab. Dispos., 27, 309, 1999.
54. Li, C. et al., Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry, Chem. Res. Toxicol., 14, 702, 2001.
55. Meng, X. et al., Formation and identification of 4′-O-methyl-(-)-epigallocatechin in humans, Drug Metab. Dispos., 29, 789, 2001.
56. Kohri, T. et al., Metabolic fate of (-)-[4-(3)H]epigallocatechin gallate in rats after oral administration, J. Agric. Food Chem., 49, 4102, 2001.
57. Katiyar, S.K. et al., (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin, Nutr. Cancer, 18, 73, 1992.
58. Katiyar, S.K. et al., Inhibition of 12-O-tetradecanoylphorbol-13-acetate and other skin tumor-promoter-caused induction of epidermal interleukin-1 alpha mRNA and protein expression in SENCAR mice by green tea polyphenols, J. Investig. Dermatol., 105, 394, 1995.
59. Pietta, P et al., Relationship between rate and extent of catechin absorption and plasma antioxidant status, Biochem. Mol. Biol. Int., 46, 895, 1998.
60. Harada, M. et al., Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin, Biosci. Biotechnol. Biochem., 63, 973, 1999.